April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Quantitating the Impact of Clinical and Basic Science Research
Author Affiliations & Notes
  • M. E. Gordon
    Ophthal & Vis Sciences,
    Washington Univ Sch of Med, St Louis, Missouri
  • C. Sarli
    Bernard Becker Library,
    Washington Univ Sch of Med, St Louis, Missouri
  • E. K. Dubinsky
    Bernard Becker Library,
    Washington Univ Sch of Med, St Louis, Missouri
  • E. Long
    Ophthal & Vis Sciences,
    Washington Univ Sch of Med, St Louis, Missouri
  • C. LaRue
    Ophthal & Vis Sciences,
    Washington Univ Sch of Med, St Louis, Missouri
  • M. A. Kass
    Ophthal & Vis Sciences,
    Washington Univ Sch of Med, St Louis, Missouri
  • Ocular Hypertension Treatment Study Group
    Washington Univ Sch of Med, St Louis, Missouri
  • Footnotes
    Commercial Relationships  M.E. Gordon, None; C. Sarli, None; E.K. Dubinsky, None; E. Long, None; C. LaRue, None; M.A. Kass, Pfizer, R; Allergan, F; Pfizer, F; Pfizer, C.
  • Footnotes
    Support  NIH Grants EY 09307, EY 09341, National Center on Minority Health and Health Disparities, Merck Research Laboratories; Pfizer, Inc. and an unrestricted grant from Research to Prevent Blindne
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2469. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. E. Gordon, C. Sarli, E. K. Dubinsky, E. Long, C. LaRue, M. A. Kass, Ocular Hypertension Treatment Study Group; Quantitating the Impact of Clinical and Basic Science Research. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2469.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To quantitate the impact of research on generation of new knowledge and change in clinical practice. Governments world-wide are demanding quantifiable outcome measures of research impact.

Methods: : We tabulated research impact using 3 criteria: (1) intellectual impact by citation counts; (2) knowledge transfer by the number of studies in new or ancillary areas; and (3) clinical impact by the adoption of findings in clinical/practice guidelines, consensus development, continuing education modules, creation of codes, insurance coverage statements, and measurement tools. As a test case, we evaluated the impact of our own clinical trial, the Ocular Hypertension Treatment Study (OHTS) which published papers in 2002 that reported the effectiveness of topical hypotensive medication in reducing the risk of glaucoma and identified central corneal thickness as a predictive factor for glaucoma.

Results: : (1) Intellectual Impact: The OHTS outcome and prediction papers were in the top 10% of cited papers published in 2002 from 25 medical and biomedical specialities. (2) New Knowledge: Five ancillary OHTS studies have been funded including research in economic analyses, genetics and ocular biomechanics. (3) Clinical Practice: Synthesis of OHTS results into clinical practice was demonstrated by the establishment of CPT I code for pachymetry in 2004; recommendation for treatment of ocular hypertension in practice guidelines, consensus conferences, curriculum materials and insurance coverage statements; development of new risk calculators for glaucoma.

Conclusions: : Systematic tabulation permits documentation of the value of clinical trials like OHTS. Basic science and clinical researchers can document impact of their research for progress reports, grant applications and promotion dossiers. We have developed an interactive website (http://becker.wustl.edu/impact/assessment/index.html) for this purpose and invite colleagues to offer suggestions to refine methods to document the impact of individual projects.

Clinical Trial: : www.clinicaltrials.gov NCT00000125

Keywords: clinical (human) or epidemiologic studies: health care delivery/economics/manpower • clinical (human) or epidemiologic studies: systems/equipment/techniques • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×